-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Whether patients with acromegaly have an increased risk of cancer remains controversial
.
In addition, the risk of benign tumors in these patients has rarely been studied
Recently, a research article was published in the Journal of Clinical Endocrinology & Metabolism, an authoritative journal in the field of endocrine and metabolic diseases.
This nationwide population-based study aims to investigate the incidence of benign and malignant tumors in patients with acromegaly
The study included 1296 patients (52% were women)
.
The average (SD) age at diagnosis was 51.
6 (14.
7) years
Original source:
Daniela Esposito.
et al.
Incidence of Benign and Malignant Tumors in Patients with Acromegaly is Increased: a Nationwide Population-Based Study .
JCEM.
2021.
https://doi.
Incidence of Benign and Malignant Tumors in Patients with Acromegaly is Increased: a Nationwide Population-Based Study in this message